Mothaffar Rimawi, MD
Baylor College of Medicine · Baylor College of Medicine, Breast Center · Baylor Breast Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Mothaffar Rimawi, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:46 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05020860 · Correlation of Clinical Response to Pathologic Response in Patients With Early Breast CancerBaylor Breast Care Center · recruiting · Breast Cancer, Breast Neoplasm, Breast Cancer Female · principal investigator
- Ph2NCT03324425 · Simvastatin Plus Dual Anti-HER2 Therapy for Metastatic Breast CancerBaylor Breast Care Center · active not recruiting · Breast Cancer Stage IV · principal investigator
- Ph2NCT02547987 · Neoadjuvant Carboplatin and Docetaxel in Triple Negative Breast CancerMothaffar Rimawi · active not recruiting · Breast Cancer · principal investigator
- Ph1NCT02074878 · CRIZENT: Crizotinib and Sunitinib in Metastatic Breast CancerMothaffar Rimawi · terminated · Breast Cancer · principal investigator
- Ph2NCT01988090 · High Dose Vitamin D vs Standard Dose Vitamin D StudyMothaffar Rimawi · terminated · Breast Cancer · principal investigator
- Ph2NCT00999804 · Extension Study of Lapatinib Plus Herceptin With or Without Endocrine TherapyBaylor Breast Care Center · active not recruiting · Breast Cancer · principal investigator
- Ph2NCT00817531 · Efficacy Study of Dasatinib in Locally Advanced Triple-Negative Breast Cancer PatientsBaylor Breast Care Center · terminated · Breast Cancer · principal investigator
- Ph2NCT00570908 · Brain Mets - Capecitabine Plus Sunitinib and WBRTBaylor Breast Care Center · terminated · Breast Cancer · principal investigator
- Ph2NCT00570323 · Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast CancerMothaffar Rimawi · completed · Breast Cancer · principal investigator
- Ph2NCT00548184 · Lapatinib and Trastuzumab With or Without Endocrine TherapyBaylor Breast Care Center · completed · Breast Cancer · principal investigator
- Ph2NCT00206518 · Taxotere and Adriamycin/Cytoxan (AC) Validation in Breast Cancer PatientsMothaffar Rimawi · completed · Breast Cancer · principal investigator
- Ph2NCT00206453 · Extension Neoadjuvant Taxotere: Study of the Effects of Taxotere in Patients With Breast CancerBaylor Breast Care Center · terminated · Breast Cancer · principal investigator
- Ph2NCT00206414 · Arimidex/Faslodex/Iressa Study: A Trial Using Arimidex, Faslodex and Iressa in Women With Breast CancerBaylor Breast Care Center · terminated · BREAST CANCER · principal investigator
- Ph2NCT00206427 · Neoadjuvant GW572016 to Treat Breast CancerBaylor Breast Care Center · completed · Breast Cancer · principal investigator
- Ph3NCT00206440 · Nexium Study To Suppress Nausea During ChemotherapyBaylor Breast Care Center · terminated · Nausea · principal investigator
- Ph2NCT00133796 · Neoadjuvant Herceptin in Patients With Breast CancerMothaffar Rimawi · terminated · BREAST CANCER · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:46 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in breast cancer.